Freedom Investment Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,811
Closed -$40K 805
2024
Q1
$40K Buy
+15,811
New +$40K ﹤0.01% 776
2022
Q2
Sell
-5,261
Closed -$216K 760
2022
Q1
$216K Sell
5,261
-319
-6% -$13.1K 0.02% 713
2021
Q4
$243K Sell
5,580
-166
-3% -$7.23K 0.02% 747
2021
Q3
$288K Sell
5,746
-721
-11% -$36.1K 0.02% 647
2021
Q2
$407K Sell
6,467
-2,920
-31% -$184K 0.03% 599
2021
Q1
$872K Sell
9,387
-5,461
-37% -$507K 0.07% 345
2020
Q4
$1.33M Sell
14,848
-11,092
-43% -$994K 0.15% 147
2020
Q3
$2.68M Sell
25,940
-3,019
-10% -$312K 0.29% 74
2020
Q2
$2.29M Sell
28,959
-3,698
-11% -$292K 0.25% 82
2020
Q1
$2M Buy
32,657
+1,345
+4% +$82.5K 0.18% 122
2019
Q4
$1.69M Sell
31,312
-3,451
-10% -$186K 0.15% 143
2019
Q3
$1.82M Sell
34,763
-5,399
-13% -$282K 0.16% 131
2019
Q2
$1.94M Sell
40,162
-3,179
-7% -$154K 0.16% 136
2019
Q1
$2.19M Sell
43,341
-3,597
-8% -$182K 0.18% 124
2018
Q4
$2.78M Sell
46,938
-12,830
-21% -$760K 0.22% 75
2018
Q3
$3.65M Buy
59,768
+4,556
+8% +$278K 0.23% 69
2018
Q2
$2.79M Buy
55,212
+4,601
+9% +$232K 0.17% 98
2018
Q1
$2.67M Buy
50,611
+10,776
+27% +$567K 0.14% 112
2017
Q4
$1.85M Buy
39,835
+2,894
+8% +$134K 0.09% 173
2017
Q3
$1.49M Sell
36,941
-1,441
-4% -$58.3K 0.08% 206
2017
Q2
$1.3M Buy
38,382
+271
+0.7% +$9.19K 0.07% 223
2017
Q1
$1.11M Sell
38,111
-7,393
-16% -$215K 0.06% 260
2016
Q4
$1.49M Sell
45,504
-6,256
-12% -$205K 0.09% 153
2016
Q3
$1.63M Sell
51,760
-8,518
-14% -$269K 0.1% 131
2016
Q2
$1.7M Buy
60,278
+7,528
+14% +$212K 0.12% 104
2016
Q1
$1.92M Sell
52,750
-8,890
-14% -$323K 0.14% 88
2015
Q4
$2.47M Buy
61,640
+57,251
+1,304% +$2.29M 0.19% 61
2015
Q3
$316K Sell
4,389
-32,870
-88% -$2.37M 0.03% 455
2015
Q2
$1.23M Buy
37,259
+10,184
+38% +$336K 0.13% 120
2015
Q1
$779K Buy
27,075
+13,676
+102% +$393K 0.09% 189
2014
Q4
$365K Buy
+13,399
New +$365K 0.05% 357